logo
[breadcrumb_custom]

Tag: MYGN

Stock

Myriad Genetics, Inc.’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

Myriad Genetics, Inc. ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $24.21 on 06/30/23, while the lowest value for the same period was recorded at $13.82 on 10/30/23. 52-week price history of MYGN Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Myriad Genetics, Inc.’s current trading price is -10.74% away from its 52-week high, while its distance from the 52-week low is 56.37%. The stock’s price range during this period has spanned from $13.82 to $24.21. In the Healthcare sector, the

Stock

A Tale of Resilience: Myriad Genetics, Inc. Amid Stock Market Turbulence

Myriad Genetics, Inc.’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $24.21 on 06/30/23, and the lowest price during that time was $13.82, recorded on 10/30/23. 52-week price history of MYGN Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Myriad Genetics, Inc.’s current trading price is -3.97% away from its 52-week high, while its distance from the 52-week low is 68.23%. The stock’s price range during this period has fluctuated between $13.82 and $24.21. Shares of the company, which operates

Industry

Myriad Genetics, Inc. (MYGN) Stock: Navigating a Year of Stock Volatility

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Myriad Genetics, Inc.’s current trading price is -3.30% away from its 52-week high, while its distance from the 52-week low is 69.39%. The stock’s price range during this period has varied between $13.82 and $24.21. The company, active in the Healthcare sector, saw a trading volume of around 0.6 million for the day, considerably lower average daily volume of 0.66 million observed over the last three months. Myriad Genetics, Inc.’s stock has seen a smooth